← All stories
Health, Longevity & Biohacking

One in Five Adults in England Taking Antidepressants Despite Lack of Evidence

Triggernometry · The Truth About Depression - Dr Joanna Moncrieff · June 24, 2026
One in Five Adults in England Taking Antidepressants Despite Lack of Evidence
Triggernometry
Triggernometry
The Truth About Depression - Dr Joanna Moncrieff
"It's something like 8.7 million people in England who take them. In England. So 1 out of 5 people of the adult population is on antidepressants? Almost 1 out of 5 are taking antidepressants, which is absolutely staggering, isn't it?"
Moncrieff disclosed that approximately 8.7 million people in England alone—nearly one in five adults—are currently taking antidepressants, a staggering figure given her assertion that there is no solid evidence these drugs correct any underlying biological problem. She expressed alarm at the scale of prescribing for medications that may be doing more harm than good by disrupting normal brain chemistry.

About this episode

In this episode of Trigonometry, hosts Konstantin Kisin and Francis Foster interviewed Dr. Joanna Moncrieff, a psychiatrist who has challenged the medical establishment's consensus on depression. Moncrieff, who published a landmark 2022 review debunking the chemical imbalance theory of depression, revealed that despite nearly one in five English adults taking antidepressants, there is no consistent evidence that depression is caused by abnormal serotonin levels or any other brain chemical imbalance. She exposed how pharmaceutical companies in the 1990s deliberately promoted this false narrative to sell SSRIs, transforming public understanding of depression from an understandable reaction to life circumstances into a medical disease requiring lifelong medication. The conversation covered the severe withdrawal effects of antidepressants, including persistent sexual dysfunction that can last years after stopping the drugs, and how the psychiatric profession has actively suppressed debate despite privately knowing the evidence was lacking. Moncrieff explained that antidepressants show minimal advantage over placebos in trials, with only a 2-point difference on a 52-point scale, and primarily work through emotional numbing rather than correcting any deficiency. She also warned that pharmaceutical companies are now pushing even more dangerous treatments including opioid-like drugs, ketamine derivatives, and psychedelics as the next wave of antidepressants, repackaging recreational drug experiences as medical treatments. The episode concluded with practical advice for those wanting to safely discontinue antidepressants, emphasizing the need for very slow tapering to avoid severe and sometimes permanent withdrawal symptoms.

Key takeaways

More stories More from Triggernometry